Gene · 389421
Papers2,505
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,505
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Layered immunity and layered leukemogenicity: Developmentally restricted mechanisms of pediatric leukemia initiation. | Immunol Rev | 2023 | 36588481 | PubTator, text mining | PubMed |
| Multiplexed transcriptome discovery of RNA-binding protein binding sites by antibody-barcode eCLIP. | Nat Methods | 2023 | 36550273 | PubTator, text mining | PubMed |
| A feedback loop between NONHSAT024276 and PTBP1 inhibits tumor progression and glycolysis in HCC by increasing the PKM1/PKM2 ratio. | Cancer Sci | 2023 | 36529521 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine. | Haematologica | 2023 | 36519323 | PubTator, text mining | PubMed |
| LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis. | Thorac Cancer | 2023 | 36516959 | PubTator, text mining | PubMed |
| RNA-binding protein LIN28A upregulates transcription factor HIF1α by posttranscriptional regulation via direct binding to UGAU motifs. | J Biol Chem | 2023 | 36509142 | PubTator, text mining | PubMed |
| Structural Plasticity of Pioneer Factor Sox2 and DNA Bendability Modulate Nucleosome Engagement and Sox2-Oct4 Synergism. | J Mol Biol | 2023 | 36495920 | PubTator, text mining | PubMed |
| CircNFIX stimulates the proliferation, invasion, and stemness properties of ovarian cancer cells by enhancing SH3RF3 mRNA stability via binding LIN28B. | Kaohsiung J Med Sci | 2023 | 36495291 | PubTator, text mining | PubMed |
| Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma. | EBioMedicine | 2023 | 36493725 | PubTator, text mining | PubMed |
| Glucose metabolism and lncRNAs in breast cancer: Sworn friend. | Cancer Med | 2023 | 36426411 | PubTator, text mining | PubMed |
| CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity. | HGG Adv | 2023 | 36425957 | PubTator, text mining | PubMed |
| Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer. | Mol Cancer Res | 2023 | 36306210 | PubTator, text mining | PubMed |
| LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA. | Gastric Cancer | 2023 | 36284068 | PubTator, text mining | PubMed |
| Identification of miR-30c-5p as a tumor suppressor by targeting the m6 A reader HNRNPA2B1 in ovarian cancer. | Cancer Med | 2023 | 36259156 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| NSUN2-mediated mRNA m5C Modification Regulates the Progression of Hepatocellular Carcinoma. | Genomics Proteomics Bioinformatics | 2023 | 36183976 | PubTator, text mining | PubMed |
| Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system. | Blood Adv | 2023 | 36053787 | PubTator, text mining | PubMed |
| A classification of genes involved in normal and delayed male puberty. | Asian J Androl | 2023 | 35532554 | PubTator, text mining | PubMed |
| Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study. | J Biomol Struct Dyn | 2023 | 35442150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/papers?page=18